Cardiff Oncology Stock Forecast - Rate Of Daily Change
CRDF Stock | USD 2.61 0.07 2.76% |
Cardiff Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of Cardiff Oncology's historical fundamentals, such as revenue growth or operating cash flow patterns.
Cardiff |
Open Interest Against 2024-12-20 Cardiff Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Cardiff Oncology's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Cardiff Oncology's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Cardiff Oncology stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Cardiff Oncology's open interest, investors have to compare it to Cardiff Oncology's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Cardiff Oncology is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Cardiff. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Previous Rate Of Daily Change | Rate Of Daily Change | Trend |
1.01 | 1.03 |
Check Cardiff Oncology Volatility | Backtest Cardiff Oncology | Information Ratio |
Cardiff Oncology Trading Date Momentum
On December 01 2024 Cardiff Oncology was traded for 2.61 at the closing time. The top price for the day was 2.69 and the lowest listed price was 2.57 . There was no trading activity during the period 0.0. Lack of trading volume on December 1, 2024 did not affect price variability. The overall trading delta against the current closing price is 1.15% . |
The rate of daily change can indicate whether a given asset was oversold or over brought during a given period.
Compare Cardiff Oncology to competition |
Other Forecasting Options for Cardiff Oncology
For every potential investor in Cardiff, whether a beginner or expert, Cardiff Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cardiff Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cardiff. Basic forecasting techniques help filter out the noise by identifying Cardiff Oncology's price trends.View Cardiff Oncology Related Equities
Risk & Return | Correlation |
Cardiff Oncology Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cardiff Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cardiff Oncology's current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Cardiff Oncology Market Strength Events
Market strength indicators help investors to evaluate how Cardiff Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardiff Oncology shares will generate the highest return on investment. By undertsting and applying Cardiff Oncology stock market strength indicators, traders can identify Cardiff Oncology entry and exit signals to maximize returns.
Cardiff Oncology Risk Indicators
The analysis of Cardiff Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cardiff Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cardiff stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 3.82 | |||
Semi Deviation | 5.99 | |||
Standard Deviation | 5.69 | |||
Variance | 32.4 | |||
Downside Variance | 53.56 | |||
Semi Variance | 35.91 | |||
Expected Short fall | (3.97) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
When determining whether Cardiff Oncology is a strong investment it is important to analyze Cardiff Oncology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cardiff Oncology's future performance. For an informed investment choice regarding Cardiff Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Cardiff Oncology to cross-verify your projections. For more detail on how to invest in Cardiff Stock please use our How to Invest in Cardiff Oncology guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardiff Oncology. If investors know Cardiff will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardiff Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.95) | Revenue Per Share 0.015 | Quarterly Revenue Growth 0.17 | Return On Assets (0.38) | Return On Equity (0.68) |
The market value of Cardiff Oncology is measured differently than its book value, which is the value of Cardiff that is recorded on the company's balance sheet. Investors also form their own opinion of Cardiff Oncology's value that differs from its market value or its book value, called intrinsic value, which is Cardiff Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardiff Oncology's market value can be influenced by many factors that don't directly affect Cardiff Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardiff Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiff Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiff Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.